The French company URGO has announced the creation of living artificial skin intended for grafting.
The product is made from living ‘universal cells’ taken from the company's own pharmaceutical-grade cell bank. The resulting skin is grown in a laboratory, after which it can be frozen, stored and transported.
According to the developers, the technology will in future make it possible to do away with autografting, the transplantation of a patient's own tissue, which currently requires several operations.
The work is the result of five years of trials under the Genesis project. Also taking part are the French National Centre for Scientific Research (CNRS), Lyon 1 University, the CECS/I-Stem research centre, the French National Blood Service and Dassault Systemes.
URGO regards the development as a significant breakthrough in the treatment of severe burns and chronic wounds. The company plans to begin grafting the artificial skin onto the first patients before 2040.